None at this time.
This U of M Program trains 100 integrative oncology (IO) leaders over 4 years and facilitates partnerships between IO leaders and complementary practitioners within their communities.
Health care workers who prepare or administer hazardous drugs (e.g., those used for cancer therapy, and some antiviral drugs, hormone agents, and bioengineered drugs) or who work in areas where these drugs are used may be exposed to these agents in the workplace. Exposure to hazardous drugs can result in adverse health effects in healthcare workers. The health risk depends on how much exposure a worker has to these drugs and how toxic they are. Workers can be protected from exposures to hazardous drugs through engineering and administrative controls, and proper protective equipment.
The Hematology/Oncology Pharmacy Association (HOPA) supports pharmacy practitioners and seeks to promote and advance hematology/oncology pharmacy to optimize the care of individuals affected by cancer.
This distinctive professional organization provides crucial education, networking, and advancement opportunities frequently sought by hematology/oncology pharmacists, pharmacy interns, residents, fellows, students, technicians, researchers, and administrators specializing in hematology/oncology pharmacy at all levels of practice.
Michigan Pharmacists Association (MPA) is the state professional society serving Michigan’s pharmacists, pharmacy technicians and student pharmacists in all settings of practices. For more than 130 years, MPA has strived to provide its members with the tools, resources and support needed to advance the profession of pharmacy and provide quality patient care.
At USP everything we do is in service of our mission to help protect and improve the health of people around the world. From the standards we create to the partnerships we foster, we continually work to build and reinforce a foundation that draws us closer to a world where everyone can be confident of quality in health and healthcare.